Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Total 13F shares
-
7,930,214
-
Share change
-
+317,322
-
Total reported value
-
$39,888,508
-
Put/Call ratio
-
90%
-
Price per share
-
$5.03
-
Number of holders
-
79
-
Value change
-
-$209,982
-
Number of buys
-
48
-
Number of sells
-
35
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q2 2023
As of 30 Jun 2023,
PDS Biotechnology Corp - Common (PDSB) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,930,214 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, TWO SIGMA ADVISERS, LP, INSPIRION WEALTH ADVISORS, LLC, LPL Financial LLC, NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.